Skip to main content

KVP Capital Advisors, LP

13F filer · CIK 0001858198
Reported Aug 13, 2026
Net seller this quarter
13F portfolio value$136MU.S. long equity reported on 13F
Positions356 new · 3 closed
Net flow last quarter-$22.9MBuys minus sells
Top 10 positions weight57.4%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 13, 202635 positions
PRAXPraxis Precision Medicines, Inc.$14.4M10.54%0.15%Not reportedQ4 2025
WHWKWhitehawk Therapeutics, Inc.$9.92M7.28%3.80%Not reportedQ4 2025
ERASErasca, Inc.$8.34M6.12%0.15%+33.8%Q1 2026
TRVITrevi Therapeutics, Inc.$7.72M5.67%0.29%Not reportedQ4 2025
STROSutro Biopharma, Inc.$7.52M5.52%1.37%Not reportedQ1 2026
TNGXTango Therapeutics, Inc.$7.2M5.28%0.14%Not reportedQ1 2026
MBXMBX Biosciences, Inc.$6.71M4.92%0.25%Not reportedQ4 2025
PTGXProtagonist Therapeutics, Inc$6.5M4.77%0.08%Not reportedQ4 2025
EWTXEdgewise Therapeutics, Inc.$5.4M3.97%0.12%Not reportedQ4 2025
TNDMTandem Diabetes Care Inc$4.54M3.33%0.43%NewQ2 2026
IRONDisc Medicine, Inc.$4.26M3.13%0.15%Not reportedQ4 2025
SVRASavara Inc$3.73M2.74%0.29%Not reportedQ4 2025
AVBPArriVent BioPharma, Inc.$3.54M2.60%0.21%NewQ2 2026
INSMINSMED Inc$3.04M2.23%0.01%Not reportedQ4 2025
ACHVAchieve Life Sciences, Inc.$3.02M2.22%0.45%Not reportedQ4 2025
IDYAIDEAYA Biosciences, Inc.$2.97M2.18%0.08%Not reportedQ1 2026
OCULOcular Therapeutix, Inc$2.95M2.16%0.14%Not reportedQ1 2026
AXSMAxsome Therapeutics, Inc.$2.94M2.16%0.02%-66.9%Q4 2025
DSGNDesign Therapeutics, Inc.$2.68M1.96%0.30%NewQ2 2026
UTHRUNITED THERAPEUTICS Corp$2.57M1.89%0.01%Not reportedQ4 2025
SRRKScholar Rock Holding Corp$2.48M1.82%0.04%Not reportedQ4 2025
IMMXImmix Biopharma, Inc.$2.38M1.74%0.32%Not reportedQ4 2025
VRDNViridian Therapeutics, Inc.\DE$2.3M1.69%0.11%Not reportedQ1 2026
MLYSMineralys Therapeutics, Inc.$2.27M1.67%0.10%NewQ2 2026
DRUGBright Minds Biosciences Inc.$2.23M1.64%0.42%Not reportedQ1 2026
TVTXTravere Therapeutics, Inc.$2.22M1.63%0.04%-57.1%Q4 2025
ZURAZura Bio Ltd$2.2M1.62%0.39%Not reportedQ1 2026
ARTVArtiva Biotherapeutics, Inc.$1.94M1.42%0.81%NewQ2 2026
NKTRNektar Therapeutics$1.88M1.38%0.13%Not reportedQ4 2025
CMPXCompass Therapeutics, Inc.$1.69M1.24%0.43%+54.2%Q1 2026
CABACabaletta Bio, Inc.$1.57M1.15%0.31%Not reportedQ4 2025
VERAVera Therapeutics, Inc.$1.4M1.03%0.05%Not reportedQ4 2025
EOLSEvolus, Inc.$1.04M0.76%0.23%NewQ2 2026
CELCCelcuity Inc.$418K0.31%0.01%Not reportedQ4 2025
VYNEYarrow Bioscience, Inc.$326K0.24%Not reportedNot reportedQ4 2025
Q1 2026Reported May 13, 202632 positions
TERNTerns Pharmaceuticals, Inc.$23.2M17.32%0.38%Not reportedQ4 2025
PRAXPraxis Precision Medicines, Inc.$13.8M10.32%0.15%Not reportedQ4 2025
WHWKWhitehawk Therapeutics, Inc.$7.47M5.58%4.59%Not reportedQ4 2025
AXSMAxsome Therapeutics, Inc.$6.12M4.57%0.07%Not reportedQ4 2025
STROSutro Biopharma, Inc.$5.64M4.22%1.37%NewQ1 2026
PTGXProtagonist Therapeutics, Inc$5.59M4.17%0.08%Not reportedQ4 2025
ERASErasca, Inc.$5.5M4.11%0.11%NewQ1 2026
TRVITrevi Therapeutics, Inc.$4.94M3.69%0.32%Not reportedQ4 2025
TNGXTango Therapeutics, Inc.$4.82M3.60%0.16%NewQ1 2026
INSMINSMED Inc$4.66M3.48%0.01%Not reportedQ4 2025
EWTXEdgewise Therapeutics, Inc.$4.19M3.13%0.12%Not reportedQ4 2025
RVMDRevolution Medicines, Inc.$3.91M2.92%0.02%+46.2%Q4 2025
IRONDisc Medicine, Inc.$3.72M2.78%0.15%Not reportedQ4 2025
MBXMBX Biosciences, Inc.$3.63M2.71%0.26%Not reportedQ4 2025
SVRASavara Inc$3.3M2.47%0.30%Not reportedQ4 2025
UTHRUNITED THERAPEUTICS Corp$2.82M2.10%0.01%Not reportedQ4 2025
TVTXTravere Therapeutics, Inc.$2.7M2.02%0.10%Not reportedQ4 2025
IDYAIDEAYA Biosciences, Inc.$2.66M1.98%0.09%NewQ1 2026
CMPXCompass Therapeutics, Inc.$2.65M1.98%0.28%NewQ1 2026
OCULOcular Therapeutix, Inc$2.54M1.90%0.14%NewQ1 2026
VRDNViridian Therapeutics, Inc.\DE$2.45M1.83%0.12%NewQ1 2026
DRUGBright Minds Biosciences Inc.$2.32M1.73%0.42%NewQ1 2026
ZURAZura Bio Ltd$2.22M1.66%0.39%NewQ1 2026
SRRKScholar Rock Holding Corp$2.21M1.65%0.04%Not reportedQ4 2025
IMMXImmix Biopharma, Inc.$2.1M1.57%0.43%Not reportedQ4 2025
SLNOSoleno Therapeutics Inc$2M1.49%0.12%Not reportedQ4 2025
NKTRNektar Therapeutics$1.94M1.45%0.13%Not reportedQ4 2025
CABACabaletta Bio, Inc.$1.36M1.02%0.45%Not reportedQ4 2025
ACHVAchieve Life Sciences, Inc.$1.36M1.02%0.87%Not reportedQ4 2025
VERAVera Therapeutics, Inc.$1.32M0.98%0.05%Not reportedQ4 2025
CELCCelcuity Inc.$457K0.34%0.01%Not reportedQ4 2025
VYNEYarrow Bioscience, Inc.$299K0.22%Not reportedNot reportedQ4 2025
Q4 2025Reported Feb 18, 202625 positions
TERNTerns Pharmaceuticals, Inc.$17.8M17.20%0.39%NewQ4 2025
PRAXPraxis Precision Medicines, Inc.$12.6M12.24%0.17%NewQ4 2025
AXSMAxsome Therapeutics, Inc.$6.61M6.40%0.07%NewQ4 2025
WHWKWhitehawk Therapeutics, Inc.$5.24M5.07%4.59%NewQ4 2025
TRVITrevi Therapeutics, Inc.$5.18M5.02%0.32%NewQ4 2025
INSMINSMED Inc$4.96M4.80%0.01%NewQ4 2025
PTGXProtagonist Therapeutics, Inc$4.63M4.48%0.08%NewQ4 2025
IRONDisc Medicine, Inc.$4.63M4.48%0.15%NewQ4 2025
MBXMBX Biosciences, Inc.$3.83M3.71%0.27%NewQ4 2025
SVRASavara Inc$3.65M3.53%0.30%NewQ4 2025
TVTXTravere Therapeutics, Inc.$3.48M3.36%0.10%NewQ4 2025
EWTXEdgewise Therapeutics, Inc.$3.3M3.19%0.13%NewQ4 2025
JAZZJazz Pharmaceuticals plc$2.98M2.88%0.03%NewQ4 2025
SLNOSoleno Therapeutics Inc$2.76M2.67%0.11%NewQ4 2025
UTHRUNITED THERAPEUTICS Corp$2.31M2.24%0.01%NewQ4 2025
ACHVAchieve Life Sciences, Inc.$2.3M2.22%0.87%NewQ4 2025
RVMDRevolution Medicines, Inc.$2.19M2.12%0.01%NewQ4 2025
SRRKScholar Rock Holding Corp$1.98M1.92%0.04%NewQ4 2025
VERAVera Therapeutics, Inc.$1.66M1.60%0.05%NewQ4 2025
IMMXImmix Biopharma, Inc.$1.21M1.17%0.44%NewQ4 2025
NKTRNektar Therapeutics$1.14M1.10%0.13%NewQ4 2025
CABACabaletta Bio, Inc.$1.11M1.07%0.50%NewQ4 2025
FULCFulcrum Therapeutics, Inc.$566K0.55%0.08%NewQ4 2025
CELCCelcuity Inc.$399K0.39%0.01%NewQ4 2025
VYNEYarrow Bioscience, Inc.$290K0.28%Not reportedNewQ4 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.